Cerebrolysin in vascular dementia - improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicentric clinical trial

被引：0
|
作者：
Guekht, A. [1 ]
Moessler, H. [2 ]
Novak, P. [2 ]
Gusev, E. [1 ]
机构：
[1] Russian State Med Univ, Moscow 117437, Russia
[2] EBEWE Neuro Pharma, Unterach, Austria
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2009年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [1] Cerebrolysin in Vascular Dementia: Improvement of Clinical Outcome in a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial
    Guekht, Alla B.
    Moessler, Herbert
    Novak, Philipp H.
    Gusev, Evgenyi I.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2011, 20 (04): : 310 - 318
  • [2] Cerebrolysin improves clinical outcome in moderate to moderately severe vascular dementia: results from a randomized, double-blind, placebo-controlled, multicenter trial
    Guekht, A.
    Doppler, E.
    Moessler, H.
    Gusev, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 391 - 391
  • [3] A double-blind, randomized, multicentric, placebo-controlled clinical trial of antarth, a phytomedicine, in the treatment of osteoarthritis
    Gupta, Anil K.
    Acharya, Kirankumar
    Sancheti, Parag S.
    Joshi, Ramchandra S.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (01) : 69 - 72
  • [4] Quetiapine treatment of psychosis associated with dementia: A double-blind, randomized, placebo-controlled clinical trial
    Tariot, Pierre N.
    Schneider, Lon
    Katz, Ira R.
    Mintzer, Jacobo E.
    Street, Jamie
    Copenhaver, Margaret
    Williams-Hughes, Celeste
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (09): : 767 - 776
  • [5] JinqiJiangtang tablets for prediabetes: A randomized, double-blind and placebo-controlled clinical trial
    Wang, Hui
    Guo, Liping
    Shang, Hongcai
    Ren, Ming
    Wang, Xuemei
    Wang, Dehui
    Chen, Jianzong
    Li, Shuanglei
    Chen, Liming
    Wang, Yue
    Liu, Zhi
    Zhai, Jingbo
    Song, Yuzhen
    Cao, Hongbo
    Zhang, Junhua
    Liu, Chunxiang
    Sun, Xiao
    Huo, Da
    Mu, Wei
    Zhang, Li
    Zheng, Wenke
    Yan, Xiaoyan
    Yao, Chen
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [6] CHOLECALCIFEROL SUPPLEMENTATION AND INFLAMMATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Seibert, Eric
    Ulrich, Christof
    Trojanowicz, Bogusz
    Lehmann, Ulrike
    Dierkes, Jutta
    Stangl, Gabriele I.
    Girndt, Matthias
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [7] An experimental, randomized, double-blind placebo-controlled clinical trial to investigate the effect of nicardipine on cognitive function inpatients with vascular dementia
    Frank, A
    Diez-Tejedor, E
    Barrerio, P
    de Leciñana, MA
    Giménez-Roldán, S
    Mateo, D
    Hipola, D
    de Andrés, C
    Navarro, E
    Gillem, D
    Dobato, JL
    de Seijas, EV
    Egido, J
    Barquero, M
    Martí-Massó, JF
    Poza, JJ
    López-Pousa, S
    Turón, A
    Lozano, M
    Aguilar, M
    Fernández-López, A
    Martinez-Yélamos, S
    Sancho-Rieger, J
    Matias-Guiu, VJ
    Pastor, I
    del Ser, T
    Cantón, R
    Lozano, R
    Mercadal, J
    Novell, R
    Secades, JJ
    [J]. REVISTA DE NEUROLOGIA, 1999, 28 (09) : 835 - 845
  • [8] Immunomodulatory Effects of Saffron: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Kianbakht, S.
    Ghazavi, A.
    [J]. PHYTOTHERAPY RESEARCH, 2011, 25 (12) : 1801 - 1805
  • [9] A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Omalizumab For Chronic Rhinosinusitis
    Mehta, N. J.
    Pinto, J.
    de Tineo, M.
    Baroody, F. M.
    Naclerio, R. M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S201 - S201
  • [10] Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial
    Ranasinghe, Priyanga
    Wathurapatha, Wasundara S.
    Galappatthy, Priyadarshani
    Katulanda, Prasad
    Jayawardena, Ranil
    Constantine, Godwin R.
    [J]. JOURNAL OF DIABETES, 2018, 10 (05) : 386 - 397
12345